Acamprosate กับการบำบัดรักษาโรคติดสุรา
Abstract
-
References
1. Heyser BJMaCJ. Acamprosate: A prototypic neuromodulator in the treatment of alcohol
dependence. CNS Neurol Disord Drug Targets. 2010 March 9(1):23–32.
2. Susanne Rösner SL, Philippe Lehert, Michael Soyka. Acamprosate Supports Abstinence,
Naltrexone Prevents Excessive Drinking: Evidence From a Meta-Analysis With Unreported
Outcomes. J Psychopharmacol. 2008 22(1):11-23.
3. Administration SAaMHS. Medication and Counseling Treatment [updated 04/09/2020. Available
from: https://www.samhsa.gov/medication-assisted-treatment/treatment.
4. Medication-Assisted Treatment (MAT) 2013 [updated 10/28/2013. Available from:
http://www.alcoholanswers.org/treatment-options/medication-assisted-treatment.cfm.
5. J. L. Acamprosate in alcohol dependence: how does it work? Addiction. 1995;90:1179–88.
6. Durbin PH, T.; Chabac, S. , editor Pharmacodynamics and pharmacokinetics of acamprosate: An
overview. In: Soyka, M., editor. Acamprosate in Relapse Prevention of Alcoholism. 1st Campral
Symposium; 1995; Stuttgart, Germany: Springer.
7. Wilde MI WAA. A review of its pharmacology and clinical potential in the management of
alcohol dependence after detoxification. Drugs. 1997;53:1038–53.
8. Lovinger DM WG, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal
neurons. Science. 1989;243:1721–4.
9. Spanagel R VV. New pharmacological treatment strategies for relapse prevention. Curr Top
Behav Neurosci. 2013;13:583–609.
10. Karl Mann FK, Rainer Spanagel, John Littleton. Acamprosate: Recent Findings and Future
Research Directions Alcoholism. 2008 July;32(7):1105-10.
11. Spanagel R KF. Drugs for relapse prevention of alcoholism: ten years of progress. Trends
Pharmacol Sci. 2008;29:109–15.
12. Bachteler D ED, Danysz W, Ciccocioppo R, Spanagel R. . The effects of acamprosate and
neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.
Neuropsychopharmacology.
13. Dahchour A DWP. Ethanol and amino acids in the central nervous system: assessment of the
pharmacological actions of acamprosate. Prog Neurobiol. 2000;60:343–62.
14. Kiefer F JH, Otte C, Demiralay C, Wolf K, Wiedemann K Increasing leptin precedes craving and
relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res.
2005;39:545– 51.
15. Lemberger T PR, Dassesse D, Westphal M, Casanova E, Turiault M, Tronche F, Schiffmann SN,
Schütz G Expression of Cre recombinase in dopaminoceptive neurons. BMC Neurosci. 2007;8:4.
16. Bolo N NJ, Muzet M, De Witte P, Dahchour A, Durbin P, Macher JP. Central effects of
acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in
healthy young male volunteers. Psychiatry Res. 1998;82:115-27.
17. Mark A. Frye, David J. Hinton, Victor M. Karpyak, Joanna M. Biernacka, Lee J. Gunderson,
Scott E. Feeder, Doo-Sup Choi and John D. Port. Anterior cingulate glutamate is reduced by
acamprosate treatment in patients with alcohol dependence. Clin Psychopharmacol. 2016
December;36(6):669-74.
18. Boeijinga PH PP, Soufflet L, Landron F, Danel T, Gendre I, Muzet M, Demazières A, Luthringer
R. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent
19. Susanne Rösner AH-H, Stefan Leucht, Philippe Lehert, Simona Vecchi, Michael Soyka.
Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews 2010(9).
dependence. CNS Neurol Disord Drug Targets. 2010 March 9(1):23–32.
2. Susanne Rösner SL, Philippe Lehert, Michael Soyka. Acamprosate Supports Abstinence,
Naltrexone Prevents Excessive Drinking: Evidence From a Meta-Analysis With Unreported
Outcomes. J Psychopharmacol. 2008 22(1):11-23.
3. Administration SAaMHS. Medication and Counseling Treatment [updated 04/09/2020. Available
from: https://www.samhsa.gov/medication-assisted-treatment/treatment.
4. Medication-Assisted Treatment (MAT) 2013 [updated 10/28/2013. Available from:
http://www.alcoholanswers.org/treatment-options/medication-assisted-treatment.cfm.
5. J. L. Acamprosate in alcohol dependence: how does it work? Addiction. 1995;90:1179–88.
6. Durbin PH, T.; Chabac, S. , editor Pharmacodynamics and pharmacokinetics of acamprosate: An
overview. In: Soyka, M., editor. Acamprosate in Relapse Prevention of Alcoholism. 1st Campral
Symposium; 1995; Stuttgart, Germany: Springer.
7. Wilde MI WAA. A review of its pharmacology and clinical potential in the management of
alcohol dependence after detoxification. Drugs. 1997;53:1038–53.
8. Lovinger DM WG, Weight FF. Ethanol inhibits NMDA-activated ion current in hippocampal
neurons. Science. 1989;243:1721–4.
9. Spanagel R VV. New pharmacological treatment strategies for relapse prevention. Curr Top
Behav Neurosci. 2013;13:583–609.
10. Karl Mann FK, Rainer Spanagel, John Littleton. Acamprosate: Recent Findings and Future
Research Directions Alcoholism. 2008 July;32(7):1105-10.
11. Spanagel R KF. Drugs for relapse prevention of alcoholism: ten years of progress. Trends
Pharmacol Sci. 2008;29:109–15.
12. Bachteler D ED, Danysz W, Ciccocioppo R, Spanagel R. . The effects of acamprosate and
neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.
Neuropsychopharmacology.
13. Dahchour A DWP. Ethanol and amino acids in the central nervous system: assessment of the
pharmacological actions of acamprosate. Prog Neurobiol. 2000;60:343–62.
14. Kiefer F JH, Otte C, Demiralay C, Wolf K, Wiedemann K Increasing leptin precedes craving and
relapse during pharmacological abstinence maintenance treatment of alcoholism. J Psychiatr Res.
2005;39:545– 51.
15. Lemberger T PR, Dassesse D, Westphal M, Casanova E, Turiault M, Tronche F, Schiffmann SN,
Schütz G Expression of Cre recombinase in dopaminoceptive neurons. BMC Neurosci. 2007;8:4.
16. Bolo N NJ, Muzet M, De Witte P, Dahchour A, Durbin P, Macher JP. Central effects of
acamprosate: part 2. Acamprosate modifies the brain in-vivo proton magnetic resonance spectrum in
healthy young male volunteers. Psychiatry Res. 1998;82:115-27.
17. Mark A. Frye, David J. Hinton, Victor M. Karpyak, Joanna M. Biernacka, Lee J. Gunderson,
Scott E. Feeder, Doo-Sup Choi and John D. Port. Anterior cingulate glutamate is reduced by
acamprosate treatment in patients with alcohol dependence. Clin Psychopharmacol. 2016
December;36(6):669-74.
18. Boeijinga PH PP, Soufflet L, Landron F, Danel T, Gendre I, Muzet M, Demazières A, Luthringer
R. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent
19. Susanne Rösner AH-H, Stefan Leucht, Philippe Lehert, Simona Vecchi, Michael Soyka.
Acamprosate for alcohol dependence. Cochrane Database of Systematic Reviews 2010(9).
Downloads
Published
2020-06-10
Issue
Section
General Article
